Publicaciones en las que colabora con JOSE ANTONIO GIRON GONZALEZ (27)

2021

  1. Neutrophil Expression of T and B Immunomodulatory Molecules in HIV Infection

    Frontiers in Immunology, Vol. 12

2020

  1. HIV antibodies level as a marker of HIV persistence: the role of hepatitis C virus coinfection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 39, Núm. 8, pp. 1503-1512

2019

  1. Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Peripheral Th17 cells expressing β7 intestinal homing receptor in recent and chronic HIV infections

    Clinical and Experimental Immunology, Vol. 194, Núm. 3, pp. 350-360

2016

  1. Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity

    World journal of gastroenterology, Vol. 22, Núm. 4, pp. 1433-1448

2015

  1. Fiebre Q aguda: riesgo de desarrollo de endocarditis

    Revista Clinica Espanola, Vol. 215, Núm. 5, pp. 265-271

  2. Immune activation response in chronic HIV-infected patients: Influence of hepatitis C virus coinfection

    PLoS ONE, Vol. 10, Núm. 3

2013

  1. Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients

    PLoS ONE, Vol. 8, Núm. 6

2012

  1. La práctica de un tratamiento antirretroviral empírico es dependiente del porcentaje de resistencias primarias del virus de la inmunodeficiencia humana

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 9, pp. 542-548

  2. La valoración de RNA del virus de la hepatitis C realizada a las 12 semanas de finalizar el tratamiento predice la respuesta virológica sostenida en enfermos con coinfección por VIH y VHC

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 1, pp. 15-17

2011

  1. Bacterial translocation in HIV-infected patients with HCV cirrhosis: Implication in hemodynamic alterations and mortality

    Journal of Acquired Immune Deficiency Syndromes, Vol. 56, Núm. 5, pp. 420-427

  2. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: The role of bacterial translocation

    Liver International, Vol. 31, Núm. 6, pp. 850-858

2010

  1. Nocardiosis

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 10, Núm. 53, pp. 3545-3551

2009

  1. Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis

    Clinical and Experimental Immunology, Vol. 158, Núm. 2, pp. 219-229

2006

  1. Structured intermittent interruption of chronic HIV infection treatment with highly active antiretroviral therapy: Effects on leptin and TNF-α

    AIDS Research and Human Retroviruses, Vol. 22, Núm. 4, pp. 307-314

  2. T cell receptor excision circles (TRECs), CD4+, CD8+ and their CD45RO+ and CD45RA+ subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: Analysis in a population on effective antiretroviral therapy

    Clinical and Experimental Immunology, Vol. 146, Núm. 2, pp. 270-277

2005

  1. Absence of favourable changes in circulating levels of interleukin-16 or β-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection

    Clinical Microbiology and Infection, Vol. 11, Núm. 1, pp. 57-62

  2. Adhesion molecules as a prognostic marker of liver cirrhosis

    Scandinavian Journal of Gastroenterology, Vol. 40, Núm. 2, pp. 217-224

2004

  1. Implication of inflammation-related cytokines in the natural history of liver cirrhosis

    Liver International, Vol. 24, Núm. 5, pp. 437-445

  2. Pneumonia in HIV-Infected Patients in the HAART Era: Incidence, Risk, and Impact of the Pneumococcal Vaccination

    Journal of Medical Virology, Vol. 72, Núm. 4, pp. 517-524